Nanoparticle Albumin Bound Paclitaxel
Nanoparticle Albumin Bound (NAB) Paclitaxel is an innovative formulation of the widely used chemotherapy drug paclitaxel. Traditional paclitaxel requires the use of chemical solvents (such as Cremophor EL) to make it soluble for intravenous administration, which often causes severe allergic reactions and requires premedication with steroids. NAB-paclitaxel avoids these issues by binding the drug molecules to albumin, a naturally occurring protein in the human body, creating a nanoparticle formulation.
This "nab-technology" offers several clinical advantages. First, it allows for the delivery of higher doses of the chemotherapy agent over a shorter infusion time with a reduced risk of hypersensitivity. Second, it utilizes the body's natural transport mechanisms; albumin is known to accumulate in tumors, which may lead to higher concentrations of the drug reaching the cancerous tissue while sparing healthy cells. This targeted approach has shown significant efficacy in treating metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer.
